New injection for easier prevention of HIV infection in the EU and worldwide

View source ↗

Summary

The European Medicines Agency announced the approval of lenacapavir as a long-acting injectable for HIV pre-exposure prophylaxis, administered every six months,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Injectable lenacapavir, administered twice yearly, is highly effective at preventing HIV